Armata Pharmaceuticals (ARMP)
(Delayed Data from AMEX)
$2.40 USD
+0.17 (7.62%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $2.37 -0.03 (-1.25%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -0.28 |
EPS Last Quarter | -0.65 |
Last EPS Surprise | -25.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.02 |
Next Year | -1.57 |
EPS (TTM) | -2.20 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.90M | 1.13M | 3.00M | 5.50M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.90M | 1.13M | 3.00M | 5.50M |
Low Estimate | 0.90M | 1.13M | 3.00M | 5.50M |
Year ago Sales | 1.23M | 1.53M | 4.53M | 3.00M |
Year over Year Growth Est. | -26.83% | -26.14% | -33.76% | 83.33% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.28 | -0.29 | -1.02 | -1.57 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.28 | -0.29 | -1.02 | -1.57 |
High Estimate | -0.28 | -0.29 | -1.02 | -1.57 |
Low Estimate | -0.28 | -0.29 | -1.02 | -1.57 |
Year ago EPS | -0.31 | -0.55 | -1.91 | -1.02 |
Year over Year Growth Est. | 9.68% | 47.27% | 46.60% | -53.92% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.28 | -0.29 | -1.02 | -1.57 |
7 Days Ago | -0.28 | -0.29 | -1.02 | -1.57 |
30 Days Ago | -0.28 | -0.29 | -1.02 | -1.57 |
60 Days Ago | -0.47 | -0.45 | -1.91 | -1.30 |
90 Days Ago | -0.47 | -0.45 | -1.91 | -1.30 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.28 | -0.29 | -1.02 | -1.57 |
Zacks Consensus Estimate | -0.28 | -0.29 | -1.02 | -1.57 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.65 | -0.69 | -0.55 | -0.31 | NA |
Estimate | -0.52 | -0.28 | NA | -0.33 | NA |
Difference | -0.13 | -0.41 | NA | 0.02 | -0.17 |
Surprise | -25.00% | -146.43% | NA | 6.06% | -55.12% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more